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Background: Portopulmonary hypertension (PPH) and hepatopulmonary syndrome (HPS) are risk factors for adverse outcomes after liver 
transplantation in adults. We sought to determine the incidence of PPH and HPS in children referred for liver transplantation.
methods: We reviewed the clinical findings, electrocardiograms (EKG) and echocardiograms in children referred for liver transplantation.
Results: Between 2010-13, 41 patients were evaluated (median age 7 months, range 1-156, 23 males). Indications for liver transplantation were 
biliary atresia (n=18; 44%) metabolic disease (n=7; 17%), total parental nutrition induced cholestasis (n=6; 15%) and miscellaneous liver disease 
(10; 24%). PPH was not detected by echocardiography. Contrast echocardiography revealed HPS in 4 cases (10%) (right to left shunt confirmed 
by radionuclide scan in 3/4) but only 2 patients (age 7 and 11 years) had severe cyanosis (right to left shunt quantified at 17-20%). Congenital 
cardiac anomalies were seen in 6 (15%) including patent ductus arteriosus (n=2), muscular ventricular septal defect, interrupted inferior vena cava 
with azygous continuation and left ventricular non-compaction, bicuspid aortic valve and supra valvar pulmonary stenosis. Septal hypertrophy was 
diagnosed by EKG (presence of deep q waves) in 16/41 (39%) and by echocardiography in 9/41 (22%). 22/41 underwent liver transplantation with 
3 deaths. Post liver transplantation resolution of septal hypertrophy was confirmed in 2/9 and right to left shunt in 3/4. One patient with PAVM died 
post liver transplant.
conclusion: In our series of young children undergoing evaluation for liver transplantation, PPH was not detected by echocardiography. HPS was 
detected in 7-10% and regressed after liver transplantation. PPH was rare in young children with end stage liver disease but septal hypertrophy, 
congenital cardiac disease and HPS were detected more frequently.
